The Value of UV Technology: You can't afford NOT to invest - Webconference
October 26, 2020
10 - 11 a.m.
Registration is open to HANYS Members Only
The studies are complete, the data are in. Focused Multivector Ultraviolet Shadowless Delivery™ disinfection technology has 99.9% efficacy and a 90-second treatment cycle.
Hear from Dina Wong, deputy executive director, Staten Island University Hospital, who recognized the benefits and long-term value PURPLESUN FMUV technology brings by strengthening the hospital’s cleaning and disinfection program, resulting in the reduction of healthcare-associated infections and improved workflow.
Objectives: Participants will learn:
- the current state of HAIs in New York hospitals and health systems;
- a high-level look at the PURPLESUN technology;
- the value of the investment; and
- how FMUV saves your hospital valuable resources.
Kathy Rauch, senior director, Quality, Advocacy, Research and Innovation, HANYS
Luis F. Romo, chief executive officer and founder, PURPLESUN
Dina Wong, deputy executive director, State Island University Hospital
Darren Finestone, president, Lion Technology Finance
If you have questions regarding registration, please contact Registration Support at email@example.com or (518) 431-7867.